Trial Profile
A Phase I/II Study of the Safety and Efficacy of Sernova's Cell Pouch for Therapeutic Islet Transplantation
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 27 Mar 2023
Price :
$35
*
At a glance
- Drugs Islet cell replacement therapy (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions; First in man; Proof of concept
- 22 Mar 2023 According to a Sernova media release, company announced that an abstract on first cohort of this trial has been selected for an oral podium presentation at the upcoming American Diabetes Association (ADA) 83rd Scientific Sessions, to be held from June 23-26, 2023, in San Diego, CA. It will also be published on the journal Diabetes website.
- 22 Dec 2016 According to a Sernova media release, this study is sponsored by JDRF.
- 22 Dec 2016 According to a Sernova media release, update on the company's corporate and business strategy will be presented at the 9th annual Biotech Showcase Conference in San Francisco.